N	O
-	O
myc	O
augments	O
death	O
and	O
attenuates	O
protective	O
effects	O
of	O
Bcl	O
-	O
2	O
in	O
trophically	O
stressed	O
neuroblastoma	B-Cell
cells	I-Cell
.	O

N	O
-	O
myc	O
has	O
proapoptotic	O
functions	O
,	O
yet	O
it	O
acts	O
as	O
an	O
oncogene	O
in	O
neuroblastoma	B-Cancer
.	O

Thus	O
,	O
antiapoptotic	O
mechanisms	O
have	O
to	O
be	O
operative	O
in	O
neuroblastoma	B-Cell
cells	I-Cell
that	O
antagonize	O
the	O
proapoptotic	O
effects	O
of	O
N	O
-	O
myc	O
.	O

We	O
conditionally	O
activated	O
N	O
-	O
myc	O
in	O
SH	B-Cell
-	I-Cell
EP	I-Cell
neuroblastoma	I-Cell
cells	I-Cell
subjected	O
to	O
the	O
trophic	O
stress	O
of	O
serum	B-Organism_substance
or	O
nutrient	O
deprivation	O
while	O
changing	O
the	O
expression	O
of	O
Bcl	O
-	O
2	O
,	O
survivin	O
and	O
FLIP	O
(	O
L	O
)	O
,	O
antiapoptotic	O
molecules	O
often	O
overexpressed	O
in	O
poor	O
prognosis	O
neuroblastomas	B-Cancer
.	O

Bcl	O
-	O
2	O
protected	O
SH	B-Cell
-	I-Cell
EP	I-Cell
cells	I-Cell
from	O
death	O
during	O
nutritional	O
deprivation	O
by	O
activating	O
energetically	O
advantageous	O
oxidative	O
phosphorylation	O
.	O

N	O
-	O
myc	O
overrode	O
the	O
metabolic	O
protection	O
provided	O
by	O
Bcl	O
-	O
2	O
-	O
induced	O
oxidative	O
phosphorylation	O
by	O
reestablishing	O
the	O
glycolytic	O
phenotype	O
and	O
attenuated	O
the	O
antiapoptotic	O
effect	O
of	O
Bcl	O
-	O
2	O
during	O
metabolic	O
stress	O
.	O

Survivin	O
partially	O
antagonized	O
the	O
growth	O
suppressive	O
function	O
of	O
N	O
-	O
myc	O
in	O
SH	B-Cell
-	I-Cell
EP	I-Cell
neuroblastoma	I-Cell
cells	I-Cell
during	O
serum	B-Organism_substance
deprivation	O
whereas	O
FLIP	O
(	O
L	O
)	O
did	O
not	O
.	O

These	O
findings	O
advance	O
our	O
understanding	O
of	O
the	O
functions	O
of	O
N	O
-	O
myc	O
in	O
neuroblastoma	B-Cell
cells	I-Cell
.	O

